HNRNPC and cancer: In HCC cells, heterogeneous nuclear ribonucleoprotein C inhibited the epithelial-mesenchymal transition through the Ras/MAPK signaling pathway, and arrested the cells in the G0/G1 phase, thereby inhibiting the cancer cell metastasis and proliferation [52].